The table below summarizes the most recent ZSAN insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why ZSAN insider buys are important for investors to follow.

Date	Insider	Price	Amount
12-6-2017 Insider Buy	Kenneth Greathouse Director	$0.61 CAGR »	$33,407.00 55,000 shares
12-1-2017 Insider Buy	Kenneth Greathouse Director	$0.62 CAGR »	$59,007.00 95,000 shares
11-15-2017 Insider Buy	Kenneth Greathouse Director	$0.62 CAGR »	$31,158.50 50,000 shares
5-25-2017 Insider Buy	John Peter Walker Interim CEO	$1.36 CAGR »	$99,891.21 73,716 shares
5-25-2017 Insider Buy	Georgia Erbez CFO and Chief Business Officer	$1.32 CAGR »	$89,760.00 68,000 shares
8-19-2016 Insider Buy	Georgia Erbez Interim CFO	$1.32 CAGR »	$63,030.00 47,750 shares
8-19-2016 Insider Buy	Donald J. Kellerman VP, Clinical Dev & Med Affairs	$1.32 CAGR »	$21,014.40 15,920 shares
8-19-2016 Insider Buy	Hayley Lewis VP, Reg Affairs & Quality	$1.32 CAGR »	$6,303.00 4,775 shares
8-19-2016 Insider Buy	Konstantinos Alataris President, CEO	$1.32 CAGR »	$168,153.48 127,389 shares
8-19-2016 Insider Buy	John Peter Walker Director	$1.32 CAGR »	$84,084.00 63,700 shares
8-19-2016 Insider Buy	Kleanthis G. Xanthopoulos Director	$1.32 CAGR »	$21,014.40 15,920 shares
1-30-2015 Insider Buy	Realty Trust Inc Biomed >10% Owner	$11.00 CAGR »	$291,973.00 26,543 shares
1-30-2015 Insider Buy	Enterprise Associates 12, Limited Partnership New >10% Owner	$11.00 CAGR »	$258,027.00 23,457 shares
1-30-2015 Insider Buy	M. James Barrett Director and >10% Owner	$11.00 CAGR »	$258,027.00 23,457 shares

Also See: Institutional Holders of ZSAN
Also See: SEC filings

Below we present the annualized performance delivered by ZSAN stock since 12-6-2017 (the date of the most recent insider purchase). The performance of the investment from the time ZSAN insider buying occurred is the ultimate test of whether insiders were right about ZSAN being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	12/07/2017
End date:	06/10/2022
Start price/share:	$399.70
End price/share:	$0.56
Dividends collected/share:	$0.00
Total return:	-99.86%
Average Annual Total Return:	-76.75%
Starting investment:	$10,000.00
Ending investment:	$13.95
Years:	4.51

ZSAN Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ZSAN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ZSAN

ZSAN — Current Quote

Quotes delayed 20 minutes

Free ZSAN Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

ZSAN — Performance

ZSAN Insider Buying

ZSAN Insider Buying | www.HoldingsChannel.com